Pfizer Inc. (PFE) is a well-known developer and distributor of biopharmaceutical products like medicines, vaccines, and other therapies. The company developed the Pfizer-BioNTech COVID-19 vaccine with BioNTech SE (BNTX).
On June 29, PFE and BNTX announced their new agreement with the U.S. government to provide 105 million doses of the COVID-19 vaccine, which might include adult Omicron-adapted COVID-19 vaccines. The government is expected to pay $3.20 billion upon receipt of the doses and has the option to purchase up to 195 million additional doses. The doses are expected to be delivered in late summer and continue into the fourth quarter.
